For decades, doctors have diagnosed some patients with stroke and others with Alzheimer’s disease, even though the vast majority of seniors have a mix of both.
Read more:
Alzheimer’s, strokes can overlap, speed dementia, researcher says
Public Citizen has petitioned the FDA to ban high doses of the Alzheimer’s drug Aricept, claiming the risks far exceed the benefits. The drug, made by Pfizer and Elsai, has been approved at doses of 5 to 10 milligrams for patients with mild to moderate Alzheimer’s, and at 10 to ... continue reading
A new blood test that will diagnose Alzheimer’s disease may soon hit the market, thanks to an innovative new study. The findings have characterized a unique biochemical diagnosis, which identifies patients with this devastating disorder.
The rest is here:
... continue reading
(Bloomberg) — Almost 15 million people care for U.S. patients with Alzheimer’s disease and dementia, providing 17 billion hours of unpaid help valued at $202.6 billion, an advocacy group said.
Read more:
Almost 15 Million in the U.S. ... continue reading
A new international report about Alzheimer’s disease suggests that the global economic impact of dementia costs about $604 billion or 1% of the global Gross Domestic Product, indicating that the financial toll of caring for patients with Alzheimer’s is substantial and expected to rise.
More here:
... continue reading